key: cord-0986731-uumyo25y
authors: Amaku, M.; Covas, D. T.; Coutinho, F. A. B.; Azevedo, R. S.; Massad, E.
title: Modelling the impact of contact tracing of symptomatic individuals on the COVID-19 epidemic
date: 2021-02-08
journal: nan
DOI: 10.1101/2021.02.05.21251222
sha: b87cbcca6205b610fb54322f2ba9eaafb427cc46
doc_id: 986731
cord_uid: uumyo25y

OBJECTIVES: With declining numbers of COVID-19 cases in the State of Sao Paulo, Brazil, social distancing measures were gradually being lifted. The risk of an increase in the number of cases, however, cannot be overlooked. Even with the adoption of non-pharmaceutical interventions, such as restrictions on mass gatherings, wearing masks, and complete or partial closure of schools, other public health measures may help to control the epidemic. We aimed to evaluate the impact of the contact tracing of symptomatic individuals on the COVID-19 epidemic regardless of the use of diagnostic testing. METHODS: We developed a mathematical model that includes isolation of symptomatic individuals and tracing of contacts to assess the effects of the contact tracing of symptomatic individuals on the COVID-19 epidemic in the State of Sao Paulo. RESULTS: For a selection efficacy (proportion of isolated contacts who are infected) of 80%, cases and deaths may be reduced by 80% after 60 days when 5000 symptomatic individuals are isolated per day, each of them together with 10 contacts. On the other hand, for a selection efficacy of 20%, the number of cases and deaths may be reduced by approximately 40% and 50%, respectively, compared with the scenario in which no contact tracing strategy is performed. CONCLUSION: Contact tracing of symptomatic individuals may be a potential alternative strategy when the number of diagnostic tests available is not sufficient for a massive testing strategy.

The first case of COVID-19 in Brazil was reported on 26 February 2020 in the State of São Paulo, the most populous Brazilian state with 44,639,899 inhabitants (1) .

Genome sequencing coupled with phylogenetic analyses corroborate multiple importations of the virus from Italy followed by local spread (2). As of 30 October 2020, 1,113,788 cases and 39,255 deaths were reported in Brazil (3), the largest numbers in Latin America (4) .

Isolation, quarantine, social distancing and community containment are important non-pharmaceutical public health interventions to control the explosive growth of COVID-19 (5) . Liberal testing, followed by contact tracing and isolation of all test positive persons have direct and clear benefits (6) .

The World Health Organization recommends a combination of rapid diagnosis, immediate isolation of cases, rigorous tracking and precautionary self-isolation of close contacts (6) . In a previous paper, we analyzed the impact and costs of test-tracequarantine strategies (7) . Here we set out to model the effects of a contact tracing strategy of symptomatic individuals to control the COVID-19 spread regardless of the use of diagnostic testing. This may be an alternative strategy for places with limited availability of diagnostic tests.

The model is based on a modified version of the SEIR model (7, 8) A schematic representation of the model is shown in Figure 1 .

The dynamics of individuals between compartments may be described as follows: is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The following set of differential equations describes the model dynamics.

The basic reproduction number of system (1) is given by is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 8, 2021. ;

The incidence of infection is given by:

The total number of reported cases is obtained by multiplying the number of infected individuals by a notification ratio

The total number of COVID-19-related deaths is given by:

Finally, the total number of isolated individuals is given by:

If the number of symptomatic individuals in a certain time interval t  is less than t I   , only the available symptomatic individuals are isolated together with their contacts. A similar procedure is adopted for the number of susceptible and asymptomatic individuals in the compartments S , E or I when they are below is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint We assumed that the potentially infective contact rate, the notification ratio, and the ICU admission rate change every 10 days.

The parameter values used are shown in Table 1 .

Model projections for future dates were obtained by keeping fixed the fitted values of the parameters from the last date observed in the data. Assuming that a fraction of the isolated contacts may be susceptible or recovered, we define a selection efficacy as the proportion of isolated contacts who are infected (asymptomatic or symptomatic individuals).

We calculated the efficacy of the CT strategy subtracting from 1 the result of the division of the cumulative number of cases by the number of cases in the baseline scenario in which CT is not performed.

We assumed an initial condition with 15%, 83% and 2% of recovered, susceptible and infected individuals. These estimates are consistent with the model projections for the beginning of August, 2020 in the State of São Paulo. Among the infected individuals, an asymptomatic-to-symptomatic ratio of 5 and a ratio of asymptomatic-to-exposed (from the compartments A and E) of 9 were assumed. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint 

A sensitivity analysis was performed using a Monte Carlo method to sample parameter values and a PRCC (Partial Rank Correlation Coefficient) estimation to measure the strength of association between an input parameter and an output variable after the linear effects on the output variable of the remaining inputs are discounted (9, 10) . Parameter values were sampled using a Monte Carlo sampling method assuming a uniform distribution for each parameter. The following input parameters were Table 2 . The cumulative number of cases after 60 days was used as the output variable.

. CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 8, 2021. ; is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 8, 2021. ; 

We fitted the model parameters simultaneously to the data of cumulative number of reported cases, deaths and the number of ICU patients (Figure 2 ) for the state of São Paulo until July 18, 2020. To estimate a 95% probability interval (shaded area in Figure   2 ), we assumed a normal distribution for the contact rate with a standard deviation of 1.0%.

The cumulative number of cases and deaths over time for different numbers (1000, 3000 or 5000) of symptomatic individuals isolated per day and their contacts (5 or 10 contacts per symptomatic individuals) are shown in Figures 3 and 4 , respectively.

Selection efficacies of 20% and 80% were taken into account. The solid line shows the results when no CT strategy was used. The efficacy of the CT strategies and the number of isolated individuals are shown in Figures 5 and 6 , respectively. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The higher the number of symptomatic individuals isolated per day, the lower the cumulative number of cases and deaths (Figures 3 and 4) . For instance, when 5000 symptomatic individuals are isolated per day, each of them together with 10 contacts, the number of cases and deaths are reduced by approximately 40% and 50%, respectively, compared with the scenario in which the CT strategy is not performed, for a selection efficacy of 20% and 60 days since the beginning of the strategy implementation. For the selection efficacy of 80%, cases and deaths are reduced by 80% approximately.

As the calculation of the efficacy of the CT strategy is based on the reduction in the number of cases, for the scenarios described in the previous example, the efficacy of the CT strategy is 40% for the selection efficacy of 20% ( Figure 5 ). For the selection efficacy of 80%, the efficacy of the CT strategy is 82% approximately. Table 2 . is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint 

We modelled the impact of a strategy based on contact tracing of symptomatic individuals on the COVID-19 epidemic in the State of São Paulo, Brazil. This strategy has lower costs when compared to a test-trace-and-quarantine strategy (7) . It may be a potential alternative strategy when the number of diagnostic tests available is not sufficient for a massive testing strategy.

In the sensitivity analysis, we observed that the reduction in the number of cumulative cases was more sensitive to the number of symptomatic individuals isolated, the selection efficacy, and the number of contacts, in decreasing order of the PRCC. The increase in the number of isolated symptomatic individuals and their contacts poses logistical challenges and associated costs. These costs, however, are likely to be lower than the costs of a test, trace and quarantine strategy (7).

The higher the selection efficacy, the higher the efficacy of the CT strategy is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 8, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 8, 2021. ; https://doi.org/10.1101/2021.02.05.21251222 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 8, 2021. ; https://doi.org/10.1101/2021.02.05.21251222 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 8, 2021. ; https://doi.org/10.1101/2021.02.05.21251222 doi: medRxiv preprint

Fundação Sistema Estadual de Análise de Dados)

Fundação Sistema Estadual de Análise de Dados)

What are the numbers out of Latin America? BBC News

Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak

COVID-19 epidemic in Switzerland: On the importance of testing, contact tracing and isolation

Modelling the test, trace and quarantine strategy to control the COVID-19 epidemic in the state of São Paulo, Brazil. Infect Dis Model

Two complementary model-based methods for calculating the risk of international spreading of a novel virus from the outbreak epicentre. The case of COVID-19

A methodology for performing global uncertainty and sensitivity analysis in systems biology

Sensitivity and uncertainty analysis of complex models of disease transmission an HIV model, as an example